Literature DB >> 23120942

Pneumocyctis pneumonia and pulmonary tuberculosis among HIV-infected patients at Muhimbili National Hospital, Tanzania.

J Mwita1, F Mugusi, K Pallangyo.   

Abstract

BACKGROUND: Respiratory infections such as pulmonary tuberculosis (PTB) and pneumonia are significant causes of morbidity and mortality in HIV infection. Recent studies have shown an increase in Pneumocystis jerovecii pneumonia (PCP) in Sub-Saharan Africa. This study determines the prevalence of PCP and other pulmonary infections among HIV patients at HIV clinics in Tanzania.
METHODS: HIV infected patients with cough were enrolled between May and November 2006. Sputum induction was done and examined for PCP using Toluidine blue stain and Polymerase chain reaction. Ziehl-Neelsen stain was also done for PTB.
RESULTS: Nine of the 125 (7.2%) had smear positive PTB. PCP was diagnosed in 10.4% (13/125) by Toluidine blue, while PCR was positive in 3.6% (3/88). Low CD4+ cell counts were associated with increased risk to both PCP and PTB.
CONCLUSION: PCP is still low in Tanzania. PTB remains the major respiratory problem in HIV patients with cough. Toluidine blue staining is not reliable for PCP diagnosis

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23120942

Source DB:  PubMed          Journal:  East Afr J Public Health        ISSN: 0856-8960


  2 in total

1.  Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania.

Authors:  A Gupta; J Mbwambo; I Mteza; S Shenoi; B Lambdin; C Nyandindi; B I Doula; S Mfaume; R D Bruce
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

2.  A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort.

Authors:  Fiona Vanobberghen; Emilio Letang; Anna Gamell; Dorcas K Mnzava; Diana Faini; Lameck B Luwanda; Herry Mapesi; Kim Mwamelo; George Sikalengo; Marcel Tanner; Christoph Hatz; Hansjakob Furrer; Manuel Battegay; Tracy R Glass
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.